Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Soluble CD26/Dipeptidyl Peptidase IV Induces T Cell Proliferation Through CD86 Up-Regulation on APCs

Published:2001-12-15 Issue:12 Volume:167 Page:6745-6755
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J Immunol

Author:

Ohnuma Kei,Munakata Yasuhiko,Ishii Tomonori,Iwata Satoshi,Kobayashi Seiji,Hosono Osamu,Kawasaki Hiroshi,Dang Nam H.,Morimoto Chikao

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference51 articles.

1. The structure and function of CD26 in the T-cell immune response

2. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

3. Regulation of the Receptor Specificity and Function of the Chemokine RANTES (Regulated on Activation, Normal T Cell Expressed and Secreted) by Dipeptidyl Peptidase IV (CD26)-mediated Cleavage

4. Dipeptidyl-peptidase IV/CD26 on T cells: analysis of an alternative T-cell activation pathway

Cited by 56 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players;Archivos de Bronconeumología;2021-12

2. Involvement of IGF Proteins in Severe Allergic Asthma: New Roles for Old Players;Archivos de Bronconeumología (English Edition);2021-12

3. Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways;Journal of Immunology Research;2021-06-02

4. Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer;MINI-REV MED CHEM;2019

5. Critical Role of Dipeptidyl Peptidase IV: A Therapeutic Target for Diabetes and Cancer;Mini-Reviews in Medicinal Chemistry;2018-12-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3